Institutional investors hold a majority ownership of DVAX through the 66.62% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2017, these large investors purchased a net $3.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GMT CAPITAL CORP. Bought 1.6 Million shares of Dynavax Technologies Corp